Friday, December 19, 2014 3:55:54 PM
Biotech Sale today......................
We had to part company with 5% more of our favorite biotech ETF today.
Note that over the last 3.25 years this holding as an AIM managed
investment has more than doubled in value. Cash now sits at 30% of the
total position value. It's average annual compound growth has been better
than 24%.
This is great performance considering the 'insurance value' of all that
cash.
We had to part company with 5% more of our favorite biotech ETF today.
Note that over the last 3.25 years this holding as an AIM managed
investment has more than doubled in value. Cash now sits at 30% of the
total position value. It's average annual compound growth has been better
than 24%.
This is great performance considering the 'insurance value' of all that
cash.
Best regards,
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
